| CTRI Number |
CTRI/2025/03/081740 [Registered on: 06/03/2025] Trial Registered Prospectively |
| Last Modified On: |
05/03/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Cosmeceuitcal] |
| Study Design |
Other |
|
Public Title of Study
|
Safety assessment of cosmetic products |
|
Scientific Title of Study
|
Dermatological safety of investigational products thorough primary irritation patch tests on healthy human Indian volunteers with sensitive skin. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| D01-6Q61-ZC-FR25; Version: 01; Dated: 19/02/2025 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pooja Yadav |
| Designation |
Principal Investigator |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA
400025
India |
| Phone |
02243349191 |
| Fax |
|
| Email |
poojayadav@mascotspincontrol.in |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Pooja Yadav |
| Designation |
Principal Investigator |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
MAHARASHTRA
400025
India |
| Phone |
02243349191 |
| Fax |
|
| Email |
poojayadav@mascotspincontrol.in |
|
Details of Contact Person
Public Query
|
| Name |
Dr Mohit Lalvani |
| Designation |
Study Director |
| Affiliation |
MASCOT-SPINCONTROL India Pvt. Ltd. |
| Address |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA
400025
India |
| Phone |
02243349191 |
| Fax |
|
| Email |
mohit.CTRI@gmail.com |
|
|
Source of Monetary or Material Support
|
| ITC LIMITED, ITC Life Sciences and Technology Centre,No. 3, 1st Main Road, Peenya Industrial
Area, I Phase Peenya, Bangalore – 560058, INDIA |
|
|
Primary Sponsor
|
| Name |
ITC LIMITED |
| Address |
ITC Life Sciences and Technology Centre,No. 3, 1st Main Road, Peenya Industrial Area, I Phase Peenya, Bangalore – 560058, INDIA |
| Type of Sponsor |
Other [Fast-Moving Consumer Goods] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pooja Yadav |
Mascot Spincontrol India Pvt. Ltd. |
Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA |
02243349191
poojayadav@mascotspincontrol.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethos- An Institutional Ethics committee (Mumbai) |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
having sensitive skin |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
13-175D |
Product application as per BIS standard |
| Intervention |
142011 |
Product application as per BIS standard |
| Intervention |
17-062 |
Product application as per BIS standard |
| Intervention |
17-086 |
Product application as per BIS standard |
| Intervention |
17-090A |
Product application as per BIS standard |
| Intervention |
17-090B |
Product application as per BIS standard |
| Intervention |
19-005A |
Product application as per BIS standard |
| Intervention |
19-005B |
Product application as per BIS standard |
| Intervention |
19-005C |
Product application as per BIS standard |
| Intervention |
19-005D |
Product application as per BIS standard |
| Intervention |
19-005E |
Product application as per BIS standard |
| Intervention |
F 374 |
Product application as per BIS standard |
| Comparator Agent |
Negative Control
(0.9% Isotonic Saline Solution) |
Product application as per BIS standard |
| Intervention |
PB-02 |
Product application as per BIS standard |
| Intervention |
PB-03 |
Product application as per BIS standard |
| Comparator Agent |
Positive control
(1% w/w SLS) |
Product application as per BIS standard |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1)Female and male Asian Indian subjects.
2)Skin is healthy on the studied anatomic unit 3)Subjects who have not participated in a similar
investigation in the past eight weeks.
4)Subjects representing sensitive skin type and varied skin type (ideally equal representation of all 4 skin types – Oily, Normal, Dry and Combination) |
|
| ExclusionCriteria |
| Details |
1)For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the
considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.
2) Having eczema, psoriasis, lichen planus, vitiligo etc. in the concerned area.
3)Having healing disorder in the concerned area.
4)Having rhinitis, allergic conjunctivitis, or rhino sinusitis.
5) Having an allergy to perfumes and/or preservatives in cosmetic products.
6)Having an allergy to plaster / adhesives used in plaster.
7) Having a food allergy.
8)Having a cardiovascular pathology that requires beta blocking treatments.
9)Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
10)Taking a retinoid-based treatment by general or oral route.
11)Taking specific treatment on the back.
12) Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study.
13)Having miliaria (prickly heat) on the back.
14) Presenting too many neavi on the back.
15) Having high pilosity on the back. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Dermatological safety / Irritation potential on skin |
Baseline,0 hrs,24 hrs & 7 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Nil |
NA |
|
|
Target Sample Size
|
Total Sample Size="35"
Sample Size from India="35"
Final Enrollment numbers achieved (Total)= "35"
Final Enrollment numbers achieved (India)="35" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
16/03/2025 |
| Date of Study Completion (India) |
18/03/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0"
Months="0"
Days="9" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Single application, Semi-occlusive and closed occlusive patch study Duration of Study:9 days as per BIS standard |